PT  - JOURNAL ARTICLE
AU  - Riddell, Anna C.
AU  - Kele, Beatrix
AU  - Harris, Kathryn
AU  - Bible, Jon
AU  - Murphy, Maurice
AU  - Dakshina, Subathira
AU  - Storey, Nathaniel
AU  - Owoyemi, Dola
AU  - Pade, Corinna
AU  - Gibbons, Joseph M.
AU  - Harrington, David
AU  - Alexander, Eliza
AU  - McKnight, Áine
AU  - Cutino-Moguel, Teresa
TI  - Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease
AID  - 10.1101/2022.01.14.21267836
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.14.21267836
4099  - http://medrxiv.org/content/early/2022/01/15/2022.01.14.21267836.short
4100  - http://medrxiv.org/content/early/2022/01/15/2022.01.14.21267836.full
AB  - The emergence of new SARS-COV-2 variants is of public health concern in case of vaccine escape. Described are three patients with advanced HIV-1 and chronic SARS-CoV-2 infection in whom there is evidence of selection and persistence of novel mutations which are associated with increased transmissibility and immune escape.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The chair of the research governance committee of Barts Health NHS Trust and Queen Mary University of London has waived ethical approval for this work on behalf of the committee.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study which is not included in the manuscript and supplementary material are available upon reasonable request to the authors http://cov-glue.cvr.gla.ac.uk/#/home